Doximity, Inc. DOCS
We take great care to ensure that the data presented and summarized in this overview for Doximity, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DOCS
View all-
Vanguard Group Inc Valley Forge, PA12.8MShares$839 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$709 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL5.22MShares$344 Million0.92% of portfolio
-
Clearbridge Investments, LLC New York, NY5.19MShares$341 Million0.27% of portfolio
-
Capital World Investors Los Angeles, CA4.28MShares$282 Million0.04% of portfolio
-
State Street Corp Boston, MA4.03MShares$265 Million0.01% of portfolio
-
Baillie Gifford & CO3.85MShares$253 Million0.22% of portfolio
-
Geode Capital Management, LLC Boston, MA3.64MShares$240 Million0.02% of portfolio
-
Franklin Resources Inc San Mateo, CA3.16MShares$208 Million0.05% of portfolio
-
Loomis Sayles & CO L P2.35MShares$154 Million0.19% of portfolio
Latest Institutional Activity in DOCS
Top Purchases
Top Sells
About DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Insider Transactions at DOCS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 03
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,000
-9.16%
|
$132,000
$66.44 P/Share
|
|
Nov 03
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,000
+8.39%
|
-
|
|
Oct 10
2025
|
Regina M. Benjamin Director |
SELL
Open market or private sale
|
Direct |
5,000
-20.13%
|
$350,000
$70.84 P/Share
|
|
Oct 10
2025
|
Regina M. Benjamin Director |
BUY
Conversion of derivative security
|
Direct |
5,000
+16.76%
|
-
|
|
Oct 01
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,000
-9.16%
|
$140,000
$70.01 P/Share
|
|
Oct 01
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,000
+8.39%
|
-
|
|
Sep 24
2025
|
Timothy S Cabral Director |
SELL
Open market or private sale
|
Direct |
20,000
-86.13%
|
$1,500,000
$75.0 P/Share
|
|
Sep 24
2025
|
Timothy S Cabral Director |
BUY
Conversion of derivative security
|
Direct |
20,000
+46.27%
|
-
|
|
Sep 12
2025
|
Regina M. Benjamin Director |
SELL
Open market or private sale
|
Direct |
5,000
-20.13%
|
$350,000
$70.5 P/Share
|
|
Sep 12
2025
|
Regina M. Benjamin Director |
BUY
Conversion of derivative security
|
Direct |
5,000
+16.76%
|
-
|
|
Sep 02
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,000
-9.16%
|
$132,000
$66.57 P/Share
|
|
Sep 02
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,000
+8.39%
|
-
|
|
Sep 02
2025
|
Timothy S Cabral Director |
SELL
Open market or private sale
|
Direct |
6,360
-66.38%
|
$419,760
$66.3 P/Share
|
|
Aug 28
2025
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+13.97%
|
-
|
|
Aug 28
2025
|
Timothy S Cabral Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+25.16%
|
-
|
|
Aug 28
2025
|
Kira Scherer Wampler Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+13.97%
|
-
|
|
Aug 28
2025
|
Watkin Phoebe L. Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+15.21%
|
-
|
|
Aug 28
2025
|
Kevin Spain |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+25.16%
|
-
|
|
Aug 26
2025
|
Anna Bryson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,000
-10.34%
|
$2,640,000
$66.76 P/Share
|
|
Aug 26
2025
|
Anna Bryson Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
40,000
+9.37%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 184K shares |
|---|---|
| Conversion of derivative security | 7.61M shares |
| Open market or private sale | 1.52M shares |
|---|---|
| Other acquisition or disposition | 6.66M shares |
| Payment of exercise price or tax liability | 66K shares |
| Bona fide gift | 200K shares |